Literature DB >> 11916504

Metastatic papillary craniopharyngioma: case study and study of tumor angiogenesis.

Lhan Elmaci1, Ozlem Kurtkaya-Yapicier, Gazanfer Ekinci, Aydin Sav, M Necmettin Pamir, Sergio Vidal, Kalman Kovacs, Bernd W Scheithauer.   

Abstract

We report a case of suprasellar papillary craniopharyngioma metastatic to the temporoparietal region 2 years after its initial resection. The literature documents examples of craniopharyngioma recurrences along the surgical tract, as well as remote ipsi- and contralateral metastases via cerebrospinal fluid seeding. Ours is the second report of a craniopharyngioma of papillary type to exhibit metastatic behavior. The tumor spread opposite the side of craniotomy. Although a rare occurrence, it confirms the limited capacity of histologically benign craniopharyngiomas to undergo meningeal seeding, likely the result of surgical manipulation. Immunohistochemical demonstration of increased microvascular density and vascular endothelial growth factor expression, as well as a high vascular endothelial growth receptor (VEGFR2) signal by in situ hybridization, suggests that tumor vascularity facilitated angiogenesis and may have been involved in the establishment and growth of the metastatic deposit.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916504      PMCID: PMC1920661          DOI: 10.1093/neuonc/4.2.123

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  8 in total

1.  Angiogenesis and the growth potential of craniopharyngiomas.

Authors:  Sergio Vidal; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 2.  Ectopic recurrence of pediatric craniopharyngiomas after gross total resection: a report of two cases and a review of the literature.

Authors:  Can Du; Cheng-Yuan Feng; Jian Yuan; Xianrui Yuan
Journal:  Childs Nerv Syst       Date:  2016-03-11       Impact factor: 1.475

Review 3.  Metastatic craniopharyngioma: case report and literature review.

Authors:  Evan Mark Frangou; Jennifer Ruth Tynan; Christopher Adam Robinson; Lissa Marie Ogieglo; Aleksander Michal Vitali
Journal:  Childs Nerv Syst       Date:  2009-06-11       Impact factor: 1.475

4.  The cell-cycle kinetics of craniopharyngioma and its clinical significance.

Authors:  Jianguo Xu; Chao You; Liangxue Zhou; Qiang Li; Peizhi Zhou; Ni Chen
Journal:  J Neurooncol       Date:  2009-11-24       Impact factor: 4.130

Review 5.  Craniopharyngioma adherence: a reappraisal of the evidence.

Authors:  Ruth Prieto; José María Pascual; Verena Hofecker; Eduard Winter; Inés Castro-Dufourny; Rodrigo Carrasco; Laura Barrios
Journal:  Neurosurg Rev       Date:  2018-07-24       Impact factor: 3.042

6.  Impact of neutrophil-lymphocyte ratio on long-term outcome in patients with craniopharyngioma.

Authors:  Jing Zhang; Min He; Zhiyong Liu; Yanlin Song; Yuelong Wang; Ruichao Liang; Hongxu Chen; Jianguo Xu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 7.  The Challenging Management of Craniopharyngiomas in Adults: Time for a Reappraisal?

Authors:  Thomas Cuny; Michael Buchfelder; Henry Dufour; Ashley Grossman; Blandine Gatta-Cherifi; Emmanuel Jouanneau; Gerald Raverot; Alexandre Vasiljevic; Frederic Castinetti
Journal:  Cancers (Basel)       Date:  2022-08-07       Impact factor: 6.575

8.  Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.

Authors:  Jianguo Xu; Sizhong Zhang; Chao You; Siqing Huang; Bowen Cai; Xiaojie Wang
Journal:  J Neurooncol       Date:  2007-04-05       Impact factor: 4.506

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.